Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 291

1.

Understanding the links between cardiovascular disease and Parkinson's disease.

Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C.

Mov Disord. 2019 Sep 4. doi: 10.1002/mds.27836. [Epub ahead of print]

PMID:
31483535
2.

Communication About OFF Periods in Parkinson's Disease: A Survey of Physicians, Patients, and Carepartners.

Rastgardani T, Armstrong MJ, Gagliardi AR, Grabovsky A, Marras C.

Front Neurol. 2019 Aug 19;10:892. doi: 10.3389/fneur.2019.00892. eCollection 2019.

3.

Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.

Carricarte Naranjo C, Marras C, Visanji NP, Cornforth DJ, Sanchez-Rodriguez L, Schüle B, Goldman SM, Estévez M, Stein PK, Lang AE, Jelinek HF, Machado A.

Clin Auton Res. 2019 Aug 23. doi: 10.1007/s10286-019-00632-w. [Epub ahead of print]

PMID:
31444591
4.

Hypertension and progressive supranuclear palsy.

Rabadia SV, Litvan I, Juncos J, Bordelon Y, Riley DE, Standaert D, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J; ENGENE PSP study.

Parkinsonism Relat Disord. 2019 Aug 3. pii: S1353-8020(19)30356-6. doi: 10.1016/j.parkreldis.2019.07.036. [Epub ahead of print]

PMID:
31420308
5.

Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.

Faust-Socher A, Duff-Canning S, Grabovsky A, Armstrong MJ, Rothberg B, Eslinger PJ, Meaney CA, Schneider RB, Tang-Wai DF, Fox SH, Zadikoff C, Kennedy N, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Reginold W, Marras C.

Dement Geriatr Cogn Disord. 2019 Jul 17:1-11. doi: 10.1159/000496454. [Epub ahead of print]

PMID:
31315127
6.

Recent developments in drug-induced movement disorders: a mixed picture.

Factor SA, Burkhard PR, Caroff S, Friedman JH, Marras C, Tinazzi M, Comella CL.

Lancet Neurol. 2019 Sep;18(9):880-890. doi: 10.1016/S1474-4422(19)30152-8. Epub 2019 Jul 3. Review.

PMID:
31279747
7.

Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade.

Marras C, Canning CG, Goldman SM.

Mov Disord. 2019 Jun;34(6):801-811. doi: 10.1002/mds.27720. Epub 2019 May 15. Review.

PMID:
31091353
8.

Reply to 'Neuropathological progression of clinical Parkinson disease subtypes'.

Espay AJ, Marras C.

Nat Rev Neurol. 2019 Jun;15(6):361-362. doi: 10.1038/s41582-019-0198-9. No abstract available.

PMID:
31048773
9.

Barriers and facilitators of communication about off periods in Parkinson's disease: Qualitative analysis of patient, carepartner, and physician Interviews.

Armstrong MJ, Rastgardani T, Gagliardi AR, Marras C.

PLoS One. 2019 Apr 18;14(4):e0215384. doi: 10.1371/journal.pone.0215384. eCollection 2019.

10.

Improving patient-centred care for persons with Parkinson's: Qualitative interviews with care partners about their engagement in discussions of "off" periods.

Rastgardani T, Armstrong MJ, Marras C, Gagliardi AR.

Health Expect. 2019 Jun;22(3):555-564. doi: 10.1111/hex.12884. Epub 2019 Apr 12.

11.

Cognitive Complaints in Nondemented Parkinson's Disease Patients and Their Close Contacts do not Predict Worse Cognitive Outcome.

AlDakheel A, Gasca-Salas C, Armstrong MJ, Duff-Canning S, Marras C.

Alzheimer Dis Assoc Disord. 2019 Apr-Jun;33(2):147-153. doi: 10.1097/WAD.0000000000000301.

PMID:
30958414
12.

Clinical Parkinson disease subtyping does not predict pathology.

Espay AJ, Marras C.

Nat Rev Neurol. 2019 Apr;15(4):189-190. doi: 10.1038/s41582-019-0153-9. No abstract available.

PMID:
30787432
13.

Concordance for Parkinson's disease in twins: A 20-year update.

Goldman SM, Marek K, Ottman R, Meng C, Comyns K, Chan P, Ma J, Marras C, Langston JW, Ross GW, Tanner CM.

Ann Neurol. 2019 Apr;85(4):600-605. doi: 10.1002/ana.25441. Epub 2019 Mar 11.

PMID:
30786044
14.

Outcome after hemispherotomy in patients with intractable epilepsy: Comparison of techniques in the Italian experience.

de Palma L, Pietrafusa N, Gozzo F, Barba C, Carfi-Pavia G, Cossu M, De Benedictis A, Genitori L, Giordano F, Russo GL, Marras CE, Pelliccia V, Rizzi S, Rossi-Espagnet C, Vigevano F, Guerrini R, Tassi L, Specchio N.

Epilepsy Behav. 2019 Apr;93:22-28. doi: 10.1016/j.yebeh.2019.01.006. Epub 2019 Feb 16.

PMID:
30780077
15.

Berardinelli-Seip syndrome and progressive myoclonus epilepsy.

Serino D, Davico C, Specchio N, Marras CE, Fioretto F.

Epileptic Disord. 2019 Feb 1;21(1):117-121. doi: 10.1684/epd.2019.1038.

PMID:
30767895
16.

22q11.2 Deletion Syndrome-Associated Parkinson's Disease.

Boot E, Bassett AS, Marras C.

Mov Disord Clin Pract. 2018 Nov 9;6(1):11-16. doi: 10.1002/mdc3.12687. eCollection 2019 Jan. Review.

PMID:
30746410
17.

Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes".

Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C.

Parkinsonism Relat Disord. 2018 Dec 28. pii: S1353-8020(18)30562-5. doi: 10.1016/j.parkreldis.2018.12.028. [Epub ahead of print] No abstract available.

PMID:
30655161
18.

We are what we eat - editors' note on the role of diet in Parkinson's disease.

Marras C, Obeso JA.

Mov Disord. 2019 Jan;34(1):1. doi: 10.1002/mds.27613. No abstract available.

PMID:
30653736
19.

Risk of Parkinson's disease dementia related to level I MDS PD-MCI.

Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2019 Mar;34(3):430-435. doi: 10.1002/mds.27617. Epub 2019 Jan 17.

PMID:
30653248
20.

Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review.

Schirinzi T, Garone G, Travaglini L, Vasco G, Galosi S, Rios L, Castiglioni C, Barassi C, Battaglia D, Gambardella ML, Cantonetti L, Graziola F, Marras CE, Castelli E, Bertini E, Capuano A, Leuzzi V.

Parkinsonism Relat Disord. 2019 Apr;61:19-25. doi: 10.1016/j.parkreldis.2018.11.019. Epub 2018 Nov 16. Review.

PMID:
30642806
21.

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease.

Yilmaz R, Strafella AP, Bernard A, Schulte C, van den Heuvel L, Schneiderhan-Marra N, Knorpp T, Joos TO, Leypoldt F, Geritz J, Hansen C, Heinzel S, Apel A, Gasser T, Lang AE, Berg D, Maetzler W, Marras C.

Front Neurol. 2018 Dec 21;9:1123. doi: 10.3389/fneur.2018.01123. eCollection 2018.

22.

Safety and efficacy of Endoscopic Third Ventriculostomy in Diffuse Intrinsic Pontine Glioma related hydrocephalus: a Systematic Review.

Guida L, Roux FE, Massimino M, Marras CE, Sganzerla E, Giussani C.

World Neurosurg. 2018 Dec 29. pii: S1878-8750(18)32919-X. doi: 10.1016/j.wneu.2018.12.096. [Epub ahead of print] Review.

PMID:
30599251
23.

MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson's Disease.

Klein C, Hattori N, Marras C.

J Parkinsons Dis. 2018;8(s1):S25-S30. doi: 10.3233/JPD-181505.

24.

The molecular landscape of glioma in patients with Neurofibromatosis 1.

D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador H, Bhat KP, Eoli M, Sanson M, Lasorella A, Iavarone A.

Nat Med. 2019 Jan;25(1):176-187. doi: 10.1038/s41591-018-0263-8. Epub 2018 Dec 10.

PMID:
30531922
25.

Understanding, Impact, and Communication of "Off" Periods in Parkinson's Disease: A Scoping Review.

Rastgardani T, Armstrong MJ, Gagliardi AR, Marras C.

Mov Disord Clin Pract. 2018 Oct 9;5(5):461-470. doi: 10.1002/mdc3.12672. eCollection 2018 Sep-Oct. Review.

PMID:
30515435
26.

Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease.

Udow SJ, Hobson DE, Kleiner G, Masellis M, Fox SH, Lang AE, Marras C.

Mov Disord Clin Pract. 2017 Nov 27;5(1):66-74. doi: 10.1002/mdc3.12563. eCollection 2018 Jan-Feb.

27.

Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review.

Trinh J, Zeldenrust FMJ, Huang J, Kasten M, Schaake S, Petkovic S, Madoev H, Grünewald A, Almuammar S, König IR, Lill CM, Lohmann K, Klein C, Marras C.

Mov Disord. 2018 Dec;33(12):1857-1870. doi: 10.1002/mds.27527. Epub 2018 Oct 24.

PMID:
30357936
28.

Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).

Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, De Uña-Álvarez J, Balboa-Barreiro V, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Mouriño-Rodríguez C, Horcada L, Sánchez-Atrio A, Montilla C, Salgado E, Díez-Álvarez E, Blanco R, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español A, Marras C, Bonilla G, Pego-Reigosa JM; RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER).

Semin Arthritis Rheum. 2019 Jun;48(6):1025-1029. doi: 10.1016/j.semarthrit.2018.09.005. Epub 2018 Sep 27.

PMID:
30344081
29.

CD34 Expression in Low-Grade Epilepsy-Associated Tumors: Relationships with Clinicopathologic Features.

Giulioni M, Marucci G, Cossu M, Tassi L, Bramerio M, Barba C, Buccoliero AM, Vornetti G, Zenesini C, Consales A, De Palma L, Villani F, Di Gennaro G, Vatti G, Zamponi N, Colicchio G, Marras CE.

World Neurosurg. 2019 Jan;121:e761-e768. doi: 10.1016/j.wneu.2018.09.212. Epub 2018 Oct 9.

PMID:
30308344
30.

Antipsychotic Drug Dispensing in Older Adults With Parkinsonism.

Marras C, Austin PC, Bronskill SE, Diong C, Rochon PA.

Am J Geriatr Psychiatry. 2018 Dec;26(12):1244-1257. doi: 10.1016/j.jagp.2018.08.003. Epub 2018 Sep 3.

PMID:
30262407
31.

Investigating Voice as a Biomarker for Leucine-Rich Repeat Kinase 2-Associated Parkinson's Disease.

Arora S, Visanji NP, Mestre TA, Tsanas A, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Lang AE, Little MA, Marras C.

J Parkinsons Dis. 2018;8(4):503-510. doi: 10.3233/JPD-181389.

32.

Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.

Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, Klein M, Rodriguez-Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RMA, Schmand BA, Tröster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D; IPMDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2018 Nov;33(11):1750-1759. doi: 10.1002/mds.110. Epub 2018 Sep 14. Review.

PMID:
30216541
33.

Pediatric intracranial ependymoma: correlating signs and symptoms at recurrence with outcome in the second prospective AIEOP protocol follow-up.

Massimino M, Barretta F, Modena P, Giangaspero F, Chiapparini L, Erbetta A, Boschetti L, Antonelli M, Ferroli P, Bertin D, Pecori E, Biassoni V, Garrè ML, Schiavello E, Sardi I, Viscardi E, Scarzello G, Mascarin M, Quaglietta L, Cinalli G, Genitori L, Peretta P, Mussano A, Barra S, Mastronuzzi A, Giussani C, Marras CE, Balter R, Bertolini P, Tornesello A, La Spina M, Buttarelli FR, Ruggiero A, Caldarelli M, Poggi G, Gandola L.

J Neurooncol. 2018 Nov;140(2):457-465. doi: 10.1007/s11060-018-2974-6. Epub 2018 Aug 14.

PMID:
30109673
34.

Brain tissue pulsatility is related to clinical features of Parkinson's disease.

Shirzadi Z, Robertson AD, Metcalfe AW, Duff-Canning S, Marras C, Lang AE, Masellis M, MacIntosh BJ.

Neuroimage Clin. 2018 Jul 23;20:222-227. doi: 10.1016/j.nicl.2018.07.017. eCollection 2018.

35.

Reproducibility of data-driven Parkinson's disease subtypes for clinical research.

Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C.

Parkinsonism Relat Disord. 2018 Nov;56:102-106. doi: 10.1016/j.parkreldis.2018.07.009. Epub 2018 Jul 20.

PMID:
30056038
36.

Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.

Cea-Calvo L, Raya E, Marras C, Salman-Monte TC, Ortiz A, Salvador G, Monteagudo I, Carmona L, Fernandez S, Arteaga MJ, Calvo-Alén J.

Rheumatol Int. 2018 Sep;38(9):1741. doi: 10.1007/s00296-018-4113-2.

PMID:
30046842
37.

Prevalence of Parkinson's disease across North America.

Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM; Parkinson’s Foundation P4 Group.

NPJ Parkinsons Dis. 2018 Jul 10;4:21. doi: 10.1038/s41531-018-0058-0. eCollection 2018.

38.

The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.

Cea-Calvo L, Raya E, Marras C, Salman-Monte TC, Ortiz A, Salvador G, Monteagudo I, Carmona L, Fernandez S, Arteaga MJ, Calvo-Allén J.

Rheumatol Int. 2018 Sep;38(9):1735-1740. doi: 10.1007/s00296-018-4097-y. Epub 2018 Jun 29. Erratum in: Rheumatol Int. 2018 Jul 25;:.

PMID:
29959469
39.

Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.

Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, Dobkin RD, Ellis T, Galvin JE, Marras C, Edwards J, Fields J, Golden R, Karlawish J, Levin B, Shulman L, Smith G, Tangney C, Thomas CA, Tröster AI, Uc EY, Coyan N, Ellman C, Ellman M, Hoffman C, Hoffman S, Simmonds D.

NPJ Parkinsons Dis. 2018 Jun 26;4:19. doi: 10.1038/s41531-018-0055-3. eCollection 2018. Review.

40.

Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease.

Kim KS, Marcogliese PC, Yang J, Callaghan SM, Resende V, Abdel-Messih E, Marras C, Visanji NP, Huang J, Schlossmacher MG, Trinkle-Mulcahy L, Slack RS, Lang AE; Canadian Lrrk2 in Inflammation Team (CLINT), Park DS.

Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5164-E5173. doi: 10.1073/pnas.1718946115. Epub 2018 May 14.

41.

The genetic nomenclature of recessive cerebellar ataxias.

Rossi M, Anheim M, Durr A, Klein C, Koenig M, Synofzik M, Marras C, van de Warrenburg BP; International Parkinson and Movement Disorder Society Task Force on Classification and Nomenclature of Genetic Movement Disorders.

Mov Disord. 2018 Jul;33(7):1056-1076. doi: 10.1002/mds.27415. Epub 2018 May 14. Review.

PMID:
29756227
42.

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, Jacquette A, Colin O, Drapier S, Borg M, Fiksinski AM, Vergaelen E, Swillen A, Vogels A, Plate A, Perandones C, Gasser T, Clerinx K, Bourdain F, Mills K, Williams NM, Wood NW, Booij J, Lang AE, Bassett AS; International Research Group on 22q11.2DS-associated Parkinson's Disease.

Neurology. 2018 Jun 5;90(23):e2059-e2067. doi: 10.1212/WNL.0000000000005660. Epub 2018 May 11.

43.

Emotion Detection Deficits and Decreased Empathy in Patients with Alzheimer's Disease and Parkinson's Disease Affect Caregiver Mood and Burden.

Martinez M, Multani N, Anor CJ, Misquitta K, Tang-Wai DF, Keren R, Fox S, Lang AE, Marras C, Tartaglia MC.

Front Aging Neurosci. 2018 Apr 24;10:120. doi: 10.3389/fnagi.2018.00120. eCollection 2018.

44.

Risk factors for non-motor symptoms in Parkinson's disease.

Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ.

Lancet Neurol. 2018 Jun;17(6):559-568. doi: 10.1016/S1474-4422(18)30127-3. Epub 2018 Apr 23. Review.

PMID:
29699914
45.

Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study.

Mestre TA, Pont-Sunyer C, Kausar F, Visanji NP, Ghate T, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kasten M, Wadia PM, Zadikoff C, Kumar P, de Bie RM, Thomsen T, Lang AE, Schüle B, Klein C, Tolosa E, Marras C.

Mov Disord. 2018 Jul;33(6):960-965. doi: 10.1002/mds.27272. Epub 2018 Apr 17.

PMID:
29665080
46.

Photogrammetry of the Human Brain: A Novel Method for Three-Dimensional Quantitative Exploration of the Structural Connectivity in Neurosurgery and Neurosciences.

De Benedictis A, Nocerino E, Menna F, Remondino F, Barbareschi M, Rozzanigo U, Corsini F, Olivetti E, Marras CE, Chioffi F, Avesani P, Sarubbo S.

World Neurosurg. 2018 Jul;115:e279-e291. doi: 10.1016/j.wneu.2018.04.036. Epub 2018 Apr 13.

PMID:
29660551
47.

Genotype-Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review.

Kasten M, Hartmann C, Hampf J, Schaake S, Westenberger A, Vollstedt EJ, Balck A, Domingo A, Vulinovic F, Dulovic M, Zorn I, Madoev H, Zehnle H, Lembeck CM, Schawe L, Reginold J, Huang J, König IR, Bertram L, Marras C, Lohmann K, Lill CM, Klein C.

Mov Disord. 2018 May;33(5):730-741. doi: 10.1002/mds.27352. Epub 2018 Apr 11.

PMID:
29644727
48.

A 21-Year Retrospective Study of the Toronto Western Hospital Deep Brain Stimulation Cohort.

Cubo E, Rajalingam R, Fasano A, Munhoz RP, Lang AE, Calvo S, Marras C.

Mov Disord. 2018 May;33(5):850-852. doi: 10.1002/mds.27359. Epub 2018 Mar 23. No abstract available.

PMID:
29570864
49.

Initial cognitive changes in Parkinson's disease.

Weintraub D, Tröster AI, Marras C, Stebbins G.

Mov Disord. 2018 Apr;33(4):511-519. doi: 10.1002/mds.27330. Epub 2018 Mar 15. Review.

50.

Corrigendum to "Increasing volume and complexity of pediatric epilepsy surgery with stable seizure outcome between 2008 and 2014: A nationwide multicenter study" [Epilepsy Behav. Oct 2017; 75C:151-157].

Barba C, Specchio N, Guerrini R, Tassi L, DeMasi S, Cardinale F, Pellacani S, De Palma L, Battaglia D, Tamburrini G, Didato G, Freri E, Consales A, Nozza P, Zamponi N, Cesaroni E, Di Gennaro G, Esposito V, Giulioni M, Tinuper P, Colicchio G, Rocchi R, Rubboli G, Giordano F, Russo GL, Marras CE, Cossu M.

Epilepsy Behav. 2018 Mar;80:380. doi: 10.1016/j.yebeh.2018.02.021. No abstract available.

PMID:
29525723

Supplemental Content

Loading ...
Support Center